These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 1650361
1. Chemical modification of the glucosidase inhibitor 1-deoxynojirimycin. Structure-activity relationships. Tan A, van den Broek L, van Boeckel S, Ploegh H, Bolscher J. J Biol Chem; 1991 Aug 05; 266(22):14504-10. PubMed ID: 1650361 [Abstract] [Full Text] [Related]
2. Introduction of oxygen into the alkyl chain of N-decyl-dNM decreases lipophilicity and results in increased retention of glucose residues on N-linked oligosaccharides. Tan A, van den Broek L, Bolscher J, Vermaas DJ, Pastoors L, van Boeckel C, Ploegh H. Glycobiology; 1994 Apr 05; 4(2):141-9. PubMed ID: 8054714 [Abstract] [Full Text] [Related]
3. Characterization of calf liver glucosidase I and its inhibition by basic sugar analogs. Schweden J, Borgmann C, Legler G, Bause E. Arch Biochem Biophys; 1986 Jul 05; 248(1):335-40. PubMed ID: 2942110 [Abstract] [Full Text] [Related]
4. Different effects of the glucosidase inhibitors 1-deoxynojirimycin, N-methyl-1-deoxynojirimycin and castanospermine on the glycosylation of rat alpha 1-proteinase inhibitor and alpha 1-acid glycoprotein. Gross V, Tran-Thi TA, Schwarz RT, Elbein AD, Decker K, Heinrich PC. Biochem J; 1986 Jun 15; 236(3):853-60. PubMed ID: 2947571 [Abstract] [Full Text] [Related]
5. Effects of the glucosidase inhibitors nojirimycin and deoxynojirimycin on the biosynthesis of membrane and secretory glycoproteins. Peyrieras N, Bause E, Legler G, Vasilov R, Claesson L, Peterson P, Ploegh H. EMBO J; 1983 Jun 15; 2(6):823-32. PubMed ID: 6227481 [Abstract] [Full Text] [Related]
6. Purification by affinity chromatography of glucosidase I, an endoplasmic reticulum hydrolase involved in the processing of asparagine-linked oligosaccharides. Hettkamp H, Legler G, Bause E. Eur J Biochem; 1984 Jul 02; 142(1):85-90. PubMed ID: 6235111 [Abstract] [Full Text] [Related]
7. Demonstration that Golgi endo-alpha-D-mannosidase provides a glucosidase-independent pathway for the formation of complex N-linked oligosaccharides of glycoproteins. Moore SE, Spiro RG. J Biol Chem; 1990 Aug 05; 265(22):13104-12. PubMed ID: 2165493 [Abstract] [Full Text] [Related]
8. Role of endoplasmic reticular calcium in oligosaccharide processing of alpha 1-antitrypsin. Kuznetsov G, Brostrom MA, Brostrom CO. J Biol Chem; 1993 Jan 25; 268(3):2001-8. PubMed ID: 8380585 [Abstract] [Full Text] [Related]
9. A vesicular intermediate in the transport of hepatoma secretory proteins from the rough endoplasmic reticulum to the Golgi complex. Lodish HF, Kong N, Hirani S, Rasmussen J. J Cell Biol; 1987 Feb 25; 104(2):221-30. PubMed ID: 3027103 [Abstract] [Full Text] [Related]
10. Effect of a glucosidase inhibitor on the bioactivity and immunoreactivity of human immunodeficiency virus type 1 envelope glycoprotein. Fenouillet E, Gluckman JC. J Gen Virol; 1991 Aug 25; 72 ( Pt 8)():1919-26. PubMed ID: 1678778 [Abstract] [Full Text] [Related]
11. Inhibition of N-linked oligosaccharide processing does not prevent the secretion of thyroglobulin. A study with swainsonine and deoxynojirimycin. Franc JL, Hovsepian S, Fayet G, Bouchilloux S. Eur J Biochem; 1986 May 15; 157(1):225-32. PubMed ID: 2940087 [Abstract] [Full Text] [Related]
12. Glucose removal from N-linked oligosaccharides is required for efficient maturation of certain secretory glycoproteins from the rough endoplasmic reticulum to the Golgi complex. Lodish HF, Kong N. J Cell Biol; 1984 May 15; 98(5):1720-9. PubMed ID: 6233287 [Abstract] [Full Text] [Related]
13. Rapid and reversible inhibition of tyrosinase activity by glucosidase inhibitors in human melanoma cells. Takahashi H, Parsons PG. J Invest Dermatol; 1992 Apr 15; 98(4):481-7. PubMed ID: 1532183 [Abstract] [Full Text] [Related]
14. Comparison between 1-deoxynojirimycin and N-methyl-1-deoxynojirimycin as inhibitors of oligosaccharide processing in intestinal epithelial cells. Romero PA, Saunier B, Herscovics A. Biochem J; 1985 Mar 15; 226(3):733-40. PubMed ID: 3157369 [Abstract] [Full Text] [Related]
15. Inhibition of myoblast fusion by the glucosidase inhibitor N-methyl-1-deoxynojirimycin, but not by the mannosidase inhibitor 1-deoxymannojirimycin. Holland PC, Herscovics A. Biochem J; 1986 Sep 01; 238(2):335-40. PubMed ID: 2948497 [Abstract] [Full Text] [Related]
16. N-methyl-N-(5-carboxypentyl)-1-deoxynojirimycin, a new affinity ligand for the purification of trimming glucosidase I. Bause E, Gross A, Schweden J. FEBS Lett; 1991 Jan 28; 278(2):167-70. PubMed ID: 1825064 [Abstract] [Full Text] [Related]
17. Effects of N-hydroxyethyl-1-deoxynojirimycin (BAY m 1099) on the activity of neutral- and acid alpha-glucosidases in human fibroblasts and HepG2 cells. Wisselaar HA, van Dongen JM, Reuser AJ. Clin Chim Acta; 1989 Jun 15; 182(1):41-52. PubMed ID: 2546700 [Abstract] [Full Text] [Related]
18. 1-deoxynojirimycin impairs oligosaccharide processing of alpha 1-proteinase inhibitor and inhibits its secretion in primary cultures of rat hepatocytes. Gross V, Andus T, Tran-Thi TA, Schwarz RT, Decker K, Heinrich PC. J Biol Chem; 1983 Oct 25; 258(20):12203-9. PubMed ID: 6226656 [Abstract] [Full Text] [Related]
19. Activation of lipoprotein lipase in cardiac myocytes by glycosylation requires trimming of glucose residues in the endoplasmic reticulum. Carroll R, Ben-Zeev O, Doolittle MH, Severson DL. Biochem J; 1992 Aug 01; 285 ( Pt 3)(Pt 3):693-6. PubMed ID: 1497606 [Abstract] [Full Text] [Related]
20. Homonojirimycin isomers and N-alkylated homonojirimycins: structural and conformational basis of inhibition of glycosidases. Asano N, Nishida M, Kato A, Kizu H, Matsui K, Shimada Y, Itoh T, Baba M, Watson AA, Nash RJ, Lilley PM, Watkin DJ, Fleet GW. J Med Chem; 1998 Jul 02; 41(14):2565-71. PubMed ID: 9651160 [Abstract] [Full Text] [Related] Page: [Next] [New Search]